Literature DB >> 6695602

Mental disorders in Parkinson's disease after treatment with L-DOPA.

P Rondot, J de Recondo, A Coignet, M Ziegler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695602

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  13 in total

1.  Hallucinosis in idiopathic Parkinson's disease.

Authors:  J M Graham; R A Grünewald; H J Sagar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.

Authors:  P Rondot; M Ziegler
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

3.  Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.

Authors:  A Moser; F Siebecker; P Vieregge; P Jaskowski; D Kömpf
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

5.  Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

Authors:  T Büttner; W Kuhn; T Müller; F L Welter; J Federlein; K Heidbrink; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 6.  Parkinson's disease.

Authors:  E C Wolters; D B Calne
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

Review 7.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

8.  Hallucinations in Parkinson disease: neuropsychological study.

Authors:  G Meco; V Bonifati; G Cusimano; E Fabrizio; N Vanacore
Journal:  Ital J Neurol Sci       Date:  1990-08

9.  Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Authors:  P Soliveri; M B Zappacosta; L Austoni; P Caffarra; A Scaglioni; D Testa; E Palazzini; T Caraceni; F Girotti
Journal:  Ital J Neurol Sci       Date:  1994-11

Review 10.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.